Alexander V. Ljubimov
Alexander V. Ljubimov graduated summa cum laude from Lomonosov Moscow State University, Moscow, Russia in 1974. From 1974 to 1991, he worked in the N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. He received his Ph.D. degree from this center in 1979 and a D.S. degree in experimental oncology in 1991. In 1991, Ljubimov received an Eleanor Roosevelt-UICC Fellowship to work in the Sanford-Burnham Medical Research Institute (previously known as Burnham Institute), La Jolla, Calif, USA, working there until 1993. Since 1993, he is working at Cedars-Sinai Medical Center, Los Angeles, Calif, USA. Presently, Dr. Ljubimov is the Director of Ophthalmology Research Laboratories at Cedars-Sinai, Professor of medicine at the David Geffen School of Medicine, University of California, Los Angeles, and Professor of surgery and biomedical sciences at Cedars-Sinai. In 2010, he was named Silver Fellow of the Association for Research in Vision and Ophthalmology. Dr. Ljubimov is an internationally recognized ophthalmic researcher and author of about 100 peer-reviewed papers, reviews, and book chapters, as well as several patents. He serves as a member of editorial boards of 9 scientific journals, National Institutes of Health Grantee since 1998, and member of various NIH and American Diabetes Association grant review panels. Dr. Ljubimov produced a panel of monoclonal antibodies to various extracellular matrix proteins manufactured by over 15 companies worldwide. His areas of interest include gene therapy for diabetic corneal disease, corneal stem cells, iPS cells, retinal and tumor angiogenesis, antiangiogenic drugs for diabetic retinopathy, and nanomedicines for cancer therapy.
Biography Updated on 18 October 2012